GlassScriptPhysician profile
Mikel Daniels
NPI 1730185091
$814.16
in general payments reported to CMS, 2019-2025
11 companies · $184 in 2025
The $184 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $161 · 2021: $60.41 · 2022: $31.93 · 2024: $148 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $331.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $347.68 | 2019-2025 | Collagenase Santyl |
| Axogen | $149.23 | 2024-2025 | Axoguard Nerve Protector, Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap |
| Allergan, INC. | $87.87 | 2020 | |
| Bioventus LLC | $83.33 | 2025 | Stimrouter Implantable Kit |
| Organogenesis INC. | $30.88 | 2021 | |
| Integra Lifesciences Corporation | $30.40 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Solventum Corporation | $27.08 | 2024 | V.A.C. Veraflo |
| Kci USA, INC. | $16.66 | 2022 | |
| Hartmann USA, INC. | $15.27 | 2022 | |
| Djo, LLC | $14.00 | 2020 | |
| B. Braun Medical INC. | $11.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mikel Daniels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.